When determining approval for Breakthrough Device designation, the FDA will consider whether the device addresses present health inequities.
The neurostimulation device, which is currently for investigational use only, aims to treat cognitive and functional decline in Alzheimer's patients.
A study published in JAMA Network Open found that increased EHR use among primary care physicians was associated with improved patient A1c levels, hypertension control and breast cancer screening rates.
The multinational pharma company will now be able to access Tempus' de-identified patient data.
The newest offering is spirometry testing to evaluate patients for chronic obstructive pulmonary disease.
The company will distribute AlertWatch to hospitals in the U.S. as part of its strategic partnership with Medtronic.
The company will use the funds to expand its platform and accelerate global commercialization.
During its earnings call this week, Walgreens' CEO said the company would invest in an organization currently achieving EBITDA.
Consumers can access HealthTap's virtual health services via a TV and a connected camera.
The company will expand its network and platform and increase R&D investments.
